San Antonio TX-based DPT Laboratories and Confab, a Montreal-based contract development and manufacturing organization and DPT subsidiary, have invested $10 million in R&D and production facilities. The capital infusion boosts Confab's lab equipment and R&D personnel, offering customers added pharmaceutical development capabilities ranging from formulation analytical/method development and tech transfer at commercial scale. The two firms merged in 2013 and are owned by Renaissance Acquisition Holdings, LLC....